Thomas Steyer’s Evolent Health EVH Stock Holding History

Thomas Steyer’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,000	Closed	-$31.9K	–	119
2026 Q1	$31.9K	Hold	14,000	–	–	﹤0.01%	170
2025 Q4	$56K	Hold	14,000	–	–	﹤0.01%	149
2025 Q3	$118K	Hold	14,000	–	–	﹤0.01%	134
2025 Q2	$158K	Hold	14,000	–	–	﹤0.01%	126
2025 Q1	$133K	Hold	14,000	–	–	﹤0.01%	130
2024 Q4	$158K	Sell	14,000 -625,000	-98%	-$11M	﹤0.01%	134
2024 Q3	$18.1M	Buy	+639,000	New	+$16.5M	0.08%	77
2024 Q2	–	Sell	-1,037,331	Closed	-$34M	–	175
2024 Q1	$34M	Sell	1,037,331 -1,126,578	-52%	-$36M	0.14%	62
2023 Q4	$71.5M	Buy	2,163,909 +263,000	+14%	+$7.44M	0.33%	53
2023 Q3	$51.8M	Hold	1,900,909	–	–	0.24%	57
2023 Q2	$57.6M	Buy	1,900,909 +757,000	+66%	+$24.5M	0.29%	65
2023 Q1	$37.1M	Buy	1,143,909 +841,909	+279%	+$26.6M	0.2%	67
2022 Q4	$8.48M	Buy	+302,000	New	+$8.66M	0.05%	114

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Thomas Steyer's EVH Position: Q2 2026 in Review

Thomas Steyer sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 14,000 shares — an estimated $31.9K sold.

Thomas Steyer first reported a position in EVH in Q4 2022 and held it in 13 quarters. The position peaked at $71.5M in Q4 2023. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Thomas Steyer reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
Thomas Steyer sold 14,000 Evolent Health shares in Q2 2026, an estimated $31.9K.
Thomas Steyer first reported a position in Evolent Health in Q4 2022 and held it in 13 quarters.
Thomas Steyer's Evolent Health position peaked at $71.5M in Q4 2023.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.